Octreotide in the medical management of chyle fistula

Otolaryngology - Head and Neck Surgery

Volumn 128, Issue 6, 2003, Pages 910-911

  Nyquist, Gurston G ^b   Hagr, Abdulrahman ^b   Sobol, Steven E ^b   Hier, Michael P ^b   Black, Martin J ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOXACILLIN; OCTREOTIDE; HORMONE;

AGED; ARTICLE; ASPIRATION BIOPSY; CASE REPORT; CHYLE FISTULA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FISTULA; HUMAN; HUMAN TISSUE; MALE; NECK TUMOR; PAPILLARY CARCINOMA; PHYSICAL EXAMINATION; POSTOPERATIVE COMPLICATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; THORACIC DUCT; THYROIDECTOMY; TREATMENT OUTCOME; CHYLE; NECK;

AGED; CHYLE; FISTULA; HORMONES; HUMANS; MALE; NECK; OCTREOTIDE;

EID: 0038263934     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0194-5998(03)00464-9     Document Type: Article

References (6)

1. Crumley RL, Smith JD. Postoperative chylous fistula prevention and management. Laryngoscope 1976;86:804-13.
2. Nussenbaum B, Liu JH, Sinard RJ. Systematic management of chyle fistula: the Southwestern experience and review of the literature. Otolaryngol Head Neck Surg 2000;122:31-8.
3. Davis SN, Granner DK. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Gilman AG, Hardman JG, Limbird LE, et al, editors. Goodman and Gilman's the pharmacological bbasis of therapeutics, 9th ed. New York: Pergamon Press; 1996. pp 1512-3.
4. Nakabayashi H, Sagara H, Usukura N, et al. Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomized dogs. Diabetes 1981;30:440-5.
5. Ulibarri JI, Sanz Y, Fuentes C, et al. Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin. Lancet 1990;336:258.
6. Kelly RF, Shumway SJ. Conservative management of postoperative chylothorax using somatostatin. Ann Thorac Surg 2000;69:1944-5.